Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...
Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...
The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...
XBI biotech ETF surged 65% as M&A heats up, but 2026 brings headwinds and tougher gains. Click here for a detailed analysis.
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback